Clinical assessment for identifying causes of acute respiratory failure in cancer patients

European Respiratory Journal

Volumn 42, Issue 2, 2013, Pages 435-443

  Schnell, David ^a,b   Mayaux, Julien ^a,b   Lambert, Jéróme ^a,b   Roux, Antoine ^a,b   Moreau, Anne Sophie ^a,b   Zafrani, Lara ^a,b   Canet, Emmanuel ^a,b   Lemiale, Virginie ^a,b   Darmon, Michael ^a,b   Azoulay, Élie ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ABNORMAL RESPIRATORY SOUND; ACUTE LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CANCER PATIENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTENSIVE CARE UNIT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SHOCK; SOLID TUMOR;

ADULT; AGED; ALGORITHMS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84882640828     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00122512     Document Type: Article

References (36)

1. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-756.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
3. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525.
4. Darmon M, Thiery G, Ciroldi M, et al. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 2007; 33: 765-772.
5. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol 2007; 25: 3274-3280.
6. Pfreundschuh M, Tru?mper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-391.
7. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
8. Bodey GP. Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents 2000; 16: 93-95.
9. Richardson PG, Sonneveld P, Schuster MW, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005; 352: 2487-2498.
10. Azoulay E, Thiéry G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004; 83: 360-370.
11. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487.
12. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808-822.
13. Azoulay E, Mokart D, Rabbat A, et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100-107.
14. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038-1046.
15. Mayaud C, Cadranel J. A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host. Thorax 2000; 55: 511-517.
16. Patel NR, Lee PS, Kim JH, et al. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest 2005; 127: 1388-1396.
17. Davies L, Mister R, Spence DP, et al. Cardiovascular consequences of fibreoptic bronchoscopy. Eur Respir J 1997; 10: 695-698.
18. Jones AM, O?Driscoll R. Do all patients require supplemental oxygen during flexible bronchoscopy? Chest 2001; 119: 1906-1909.
19. Weiss SM, Hert RC, Gianola FJ, et al. Complications of fiberoptic bronchoscopy in thrombocytopenic patients. Chest 1993; 104: 1025-1028.
20. Bauer TT, Torres A, Ewig S, et al. Effects of bronchoalveolar lavage volume on arterial oxygenation in mechanically ventilated patients with pneumonia. Intensive Care Med 2001; 27: 384-393.
21. Verra F, Hmouda H, Rauss A, et al. Bronchoalveolar lavage in immunocompromised patients. Clinical and functional consequences. Chest 1992; 101: 1215-1220.
22. Du Rand IA, Barber PV, Goldring J, et al. Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax 2011; 66: 1014-1015.
23. Ran?ó A, Agust?́ C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001; 56: 379-387.
24. Azoulay E, de Miranda S, Bèle N, et al. Stratégie diagnostique dans l?insuffisance respiratoire aigue? des patients d?oncohématologie. [Diagnostic strategy for acute respiratory failure in patients with haematological malignancy]. Rev Mal Respir 2008; 25: 433-449.
25. Camous L, Lemiale V, Kouatchet A, et al. Minimally invasive diagnostic strategy in immunocompromised patients with pulmonary infiltrates. In: Azoulay E, ed. Pulmonary Involvement in Patients with Hematological Malignancies. Berlin, Springer-Verlag, 2011; pp. 175-190.
26. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: e56-e93.
27. Karnofsky DA, Abelmann WH, Craver LF. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-656.
28. Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA 1996; 276: 802-810.
29. Afessa B, Tefferi A, Litzow MR, et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 1364-1368.
30. Gentile G, Donati PP, Capobianchi A, et al. Evaluation of a score system for the severity and outcome of cytomegalovirus interstitial pneumonia in allogeneic bone marrow recipients. J Infect 1997; 35: 117-123.
31. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
32. Azoulay E, Mayaud C. Pnemopathie à Candida: mythe ou réalité? [Candida pneumopathy: fact or fiction?]. Rev Pneumol Clin 1999; 55: 349-351.
33. Azoulay E, Soares M, Darmon M, et al. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5.
34. Gruson D, Hilbert G, Valentino R, et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 2000; 28: 2224-2230.
35. Lecuyer L, Chevret S, Thiery G, et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814.
36. Bollée G, Sarfati C, Thiery G, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest 2007; 132: 1305-1310.